Section Policies
Abbott Laboratories
Abbott Laboratories
![]() |
![]() |
![]() |
AstraZeneca
AstraZeneca
![]() |
![]() |
![]() |
Bayer Healthcare
Bayer Healthcare
![]() |
![]() |
![]() |
Bristol-Myers Squibb
Bristol-Myers Squibb
![]() |
![]() |
![]() |
Eli Lilly
Eli Lilly
![]() |
![]() |
![]() |
GlaxoSmithKline
GlaxoSmithKline
![]() |
![]() |
![]() |
Johnson & Johnson
Johnson & Johnson
![]() |
![]() |
![]() |
Merck & Co
Merck & Co
![]() |
![]() |
![]() |
Novartis
Novartis
![]() |
![]() |
![]() |
Pfizer
Pfizer
![]() |
![]() |
![]() |
Roche
F. Hoffman La-Roche
![]() |
![]() |
![]() |
Sanofi
Sanofi
![]() |
![]() |
![]() |
Quarterly Review
![]() |
![]() |
![]() |
Open Access Policy
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.